Aripiprazole-d8 is a deuterated version of Aripiprazole, which is a selective D2DR (dopamine D2-receptor) antagonist with dopamine autoreceptor agonist activity. Users have reported separation of this compound and aripiprazole under reverse-phase H and normal-phase.
1. Oshiro, Y., et al., 1998. Novel antipsychotic agents with dopamine autoreceptor agonist properties: synthesis and pharmacology of 7-[4-(4-phenyl-1-piperazinyl)butoxy]-3,4-dihydro-2(1H)-quinolinone derivatives. Journal of medicinal chemistry. 41(5): 658-67. PMID: 9513593
2. Cañive, J M., et al., 1998. Spontaneous brain magnetic activity in schizophrenia patients treated with aripiprazole. Psychopharmacology bulletin. 34(1): 101-5. PMID: 9580382